Frankfurt - Delayed Quote EUR
Imunon, Inc. (CBO.F)
0.5300
-0.1650
(-23.74%)
As of 8:12:18 AM GMT+2. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
0
0
0
500
500
Operating Expense
19,132.4460
19,132.4460
21,030.4300
25,421.5650
21,507.1900
Operating Income
-19,132.4460
-19,132.4460
-21,030.4300
-24,921.5650
-21,007.1900
Net Non Operating Interest Income Expense
450.2210
450.2210
528.7440
-4,526.0400
-551.7360
Other Income Expense
61.9830
61.9830
-293.6760
-8,017.6550
-593.7700
Pretax Income
-18,620.2420
-18,620.2420
-20,795.3620
-37,465.2600
-22,152.6960
Tax Provision
0
0
-1,280.3850
-1,567.0260
-1,383.4460
Net Income Common Stockholders
-18,620.2420
-18,620.2420
-19,514.9770
-35,898.2340
-20,769.2500
Diluted NI Available to Com Stockholders
-18,620.2420
-18,620.2420
-19,514.9770
-35,898.2340
-20,769.2500
Basic EPS
-1.91
-1.62
-2.16
-5.03
-3.83
Diluted EPS
-1.91
-1.62
-2.16
-5.03
-3.83
Basic Average Shares
10,228.2600
11,508.1590
9,045.3200
7,143
5,424.3140
Diluted Average Shares
10,228.2600
11,508.1590
9,045.3200
7,143
5,424.3140
Total Operating Income as Reported
-19,132.4460
-19,132.4460
-21,030.4300
-24,921.5650
-21,007.1900
Total Expenses
19,132.4460
19,132.4460
21,030.4300
25,421.5650
21,507.1900
Net Income from Continuing & Discontinued Operation
-18,620.2420
-18,620.2420
-19,514.9770
-35,898.2340
-20,769.2500
Normalized Income
-18,682.2250
-18,682.2250
-19,611.3588
-28,207.5757
-20,210.5125
Interest Income
450.2210
450.2210
725.8240
502.5780
18.1450
Interest Expense
0
0
197.0800
5,028.6180
569.8810
Net Interest Income
450.2210
450.2210
528.7440
-4,526.0400
-551.7360
EBIT
-18,620.2420
-18,620.2420
-20,598.2820
-32,436.6420
-21,582.8150
EBITDA
-17,902.1260
-17,902.1260
-19,878.2770
-31,705.0130
-20,879.8970
Reconciled Depreciation
718.1160
718.1160
720.0050
731.6290
702.9180
Net Income from Continuing Operation Net Minority Interest
-18,620.2420
-18,620.2420
-19,514.9770
-35,898.2340
-20,769.2500
Total Unusual Items Excluding Goodwill
61.9830
61.9830
102.6430
-8,019.4560
-595.6690
Total Unusual Items
61.9830
61.9830
102.6430
-8,019.4560
-595.6690
Normalized EBITDA
-17,964.1090
-17,964.1090
-19,980.9200
-23,685.5570
-20,284.2280
Tax Rate for Calcs
0
0
0.0001
0
0.0001
Tax Effect of Unusual Items
0
0
6.2612
-328.7977
-36.9315
12/31/2021 - 10/18/2012
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
THAR Tharimmune, Inc.
1.4000
-2.10%
KZR Kezar Life Sciences, Inc.
4.1300
-1.67%
RENB Renovaro Inc.
0.3300
-1.55%
IMUX Immunic, Inc.
0.9772
-1.27%
PBYI Puma Biotechnology, Inc.
2.9000
-3.65%
XFOR X4 Pharmaceuticals, Inc.
3.2400
-2.11%
IONS Ionis Pharmaceuticals, Inc.
32.60
+0.22%
LXRX Lexicon Pharmaceuticals, Inc.
0.5319
-15.57%
ABCL AbCellera Biologics Inc.
2.0500
-2.38%